The streptozocin model of diabetes, induces neuropathic pain & changes in quality of life measures which can be modulated by social interaction/welfare

Keyphrases

• Neuropathic Pain 100%
• Quality of Life Assessment 100%
• Streptozotocin 100%
• Diabetes 100%
• Social Interaction 100%
• Burrow 45%
• Diabetic Rats 36%
• Hyperglycemia 13%
• Diabetic Patients 9%
• Well-being 9%
• Sucrose Preference 9%
• Pregabalin 9%
• Analgesic 9%
• Positive Impact 9%
• Anhedonia 9%
• Rodents 9%
• Social Grouping 9%
• Negative Impact 4%
• Stress Diabetes 4%
• Change from Baseline 4%
• Between-day 4%
• Patient Experience 4%
• Allodynia 4%
• Wistar Rats 4%
• Pair-housed 4%
• Affective Well-being 4%
• Objective Quality of Life 4%
• Static Allodynia 4%
• Nociceptive Behavior 4%
• Day 14 4%
• Analgesia 4%
• Nociceptive Response 4%
• Animals (scientific procedures) Act 1986 4%
• Home Cage 4%
• Predictive Validity 4%
• Rapid Change 4%
• Chronic Neuropathic Pain 4%
• Mechanical Allodynia 4%
• Response Behavior 4%
• Polydypsia 4%
• Quality of Life 4%
• Citrate Buffer 4%
• Sustained Change 4%

Neuroscience

• Neuropathic Pain 100%
• Social Interaction 100%
• Streptozotocin 100%
• Diabetes Mellitus 31%
• Behavior (Neuroscience) 18%
• Hyperglycemia 13%
• Allodynia 13%
• Anhedonia 9%
• Pregabalin 9%
• Analgesic 4%
• Polydipsia 4%